Short-acting β2-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study

BACKGROUNDTo gain a global perspective on short-acting β2-agonist (SABA) prescriptions and associated asthma-related clinical outcomes in patients with asthma, we assessed primary health data across 24 countries in five continents. METHODSSABINA III was a cross-sectional study that employed electron...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The European respiratory journal 2022-05, Vol.59 (5)
Hauptverfasser: Bateman, Eric D, Price, David B, Wang, Hao-Chien, Khattab, Adel, Schonffeldt, Patricia, Catanzariti, Angelina, van der Valk, Ralf J P, Beekman, Maarten J H I
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!